Hepatitis B virus in the Arab world: Where do we stand?

Arab Journal of Gastroenterology

Volumn 14, Issue 2, 2013, Pages 35-43

  Gasim, Gasim Ibrahim ^a  

^a QASSIM UNIVERSITY   (Saudi Arabia)

Author keywords

Epidemiology; Hepatitis B; Hepatitis B surface antigen (HBsAg); Prevalence; Sero epidemiological studies

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

CHRONIC HEPATITIS; CULTURAL ANTHROPOLOGY; EGYPT; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LEBANON; LIBYAN ARAB JAMAHIRIYA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MORTALITY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

FEMALE; GENOTYPE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE EAST; PREVALENCE;

EID: 84879785433     PISSN: 16871979     EISSN: 20902387     Source Type: Journal    
DOI: 10.1016/j.ajg.2013.04.002     Document Type: Review

References (100)

1. Mahgoub S., Candotti D., El Ekiaby M., Allain J.P. Hepatitis B virus (HBV) infection and recombination between HBV genotypes D and E in asymptomatic blood donors from Khartoum. Sudan. J Clin Microbiol 2011, 49:298-306.
2. Harkisoen S., Arends J.E., Van Erpecum K.J., Van den Hoek A., Hoepelman A.I. Hepatitis B viral load and risk of HBV-related liver disease: from East to West?. Ann Hepatol 2012, 11:164-171.
3. World Health Organization. Hepatitis B. World Health Organization Fact Sheet 204 2008. Available from: <>. http://www.who.int/mediacentre/factsheet/fs204/en.
4. World Health Organization. Sixty third world health assembly 25. World Health Organization 2011. Available from: <>. http://apps.who.int/gb/ebwha/pdffiles/WHA63/A63_15-en.pdf.
5. Ott J.J., Stevens G.A., Groeger J., Wiersma S.T. Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 2012, 30:2212-2219.
6. Elbadawi, Ibrahim A. Reviving growth in the Arab world. Econ Dev Cult Change 2005, 53:293-326.
7. CDC, Yellow book, Infectious diseases related to travel, Hepatitis B 2011. <>. [Chapter 3]. http://wwwnc.cdc.gov/travel/yellowbook/2010/chapter-2/hepatitis-b.aspx.
8. Daw M.A., Shawky S. Going beyond the curriculum to promote medical education and practice (multiple letters). Saudi Med J 2002, 23:116-117.
9. Daw M., Elkhammas E. Libyan medical education; time to move forward. Libyan J Med 2008, 3:1-3.
10. Culcasi Karen CULCASI. Constructing and naturalizing the Middle East. Geogr Rev 2010, 100:583-597.
11. Faleh Zaid Al-Faleh FACHARTZ. Changing pattern of Hepatitis viral infection in Saudi Arabia in the last two decades. Ann Saudi Med 2003, 23:361-365.
12. Kamel E., El Beltagy A., Ibrahem A., Al Balawi B., Maha Almuneef A., Ziad A. Memish: prevalence of hepatitis B virus markers among blood donors in a tertiary hospital in Tabuk, northwestern Saudi Arabia. Int J Infect Dis 2008, 12:495-499.
13. Abdo A.A., Al-Jarallah B.M., Sanai F.M., Hersi A.S., Al-Swat K., Azzam N.A., et al. Hepatitis B genotypes: relation to clinical outcome in patients with chronic hepatitis B in Saudi Arabia. World J Gastroenterol 2006, 12:7019-7024.
14. Memish Z.A., Knawy B.A., El-Saed A. Incidence trends of viral hepatitis A, B, and C seropositivity over eight years of surveillance in Saudi Arabia. Int J Infect Dis 2010, 14:e20-e115.
15. Lavanchy D. Chronic viral hepatitis as a public health issue in the world. Best Pract Res Clin Gastroenterol 2008, 22:991-1008.
16. Al-Waleedi A.A., Khader Y.S. Prevalence of hepatitis B and C infections and associated factors among blood donors in Aden City, Yemen. East Mediterr Health J 2012, 18:624-629.
17. Alfaresi M., Elkoush A., Alshehhi H., Alzaabi A., Islam A. Hepatitis B virus genotypes and precore and core mutants in UAE patients. Virol J 2010, 7:160.
18. Ameen R., Sanad N., Al-Shemmari S., Siddique I., Chowdhury R.I., Al-Hamdan S., et al. Prevalence of viral markers among first-time Arab blood donors in Kuwait. Transfusion 2005, 45:1973-1980.
19. Allain J.P. Epidemiology of Hepatitis B virus and genotype. J Clin Virol 2006, 36(Suppl. 1):S7-S12.
20. Qadi A.A., Tamim H., Ameen G., Bu-Ali A., Al-Arrayed S., Fawaz N.A., et al. Hepatitis B and hepatitis C virus prevalence among dialysis patients in Bahrain and Saudi Arabia: a survey by serologic and molecular methods. Am J Infect Control 2004, 32:493-495.
21. Njoh J. Prevalence of hepatitis B virus markers among drug-dependent patients in Jeddah Saudi Arabia. East Afr Med J 1995, 72:490-491.
22. Al Awaidy S., Abu-Elyazeed R., Al Hosani H., Al Mulla A., Al Busaiedy S., Al Amiry A., et al. Sero-epidemiology of hepatitis B infection in pregnant women in Oman, Qatar and the United Arab Emirates. J Infect 2006, 52:202-206.
23. Al-Dhahry S.S., Aghanashinikar P.N., Al-Marhuby H.A., Buhl M.R., Daar A.S., Al.-Hasani M.K., et al. Hepatitis B, delta and human immunodeficiency virus infections among Omani patients with renal diseases: a seroprevalence study. Ann Saudi Med 1994, 14:312-315.
24. al-Mahroos F.T., Ebrahim A. Prevalence of hepatitis B, hepatitis C and human immune deficiency virus markers among patients with hereditary haemolytic anaemias. Ann Trop Paediatr 1995, 15:121-128.
25. Ataallah T.M., Hanan K.A., Maysoun K.S., Sadoon A.A. Prevalence of hepatitis B and C among blood donors attending the National blood transfusion center in Baghdad, Iraq from 2006-2009. Saudi Med J 2011, 32:1046-1050.
26. Saab B.R., Nassar N.T., Musharrafieh U., Araj G.F., Khogali M. Prevalence of hepatitis B in a presumably healthy Lebanese population. J Med Liban 2007, 55:11-14.
27. Fathi Abed Al-Gani Prevalence of HBV, HCV and HIV-1, 2 infections among blood donors in Prince Rashed Ben Al-Hassan hospital in North region of Jordan. Int J Biol Med Res 2011, 2:912-916.
28. Yassin K., Awad R., Tebi A.J., Queder A., Laaser U. Prevalence and risk factors of HBsAg in Gaza: implications for prevention and control. J Infect 2002, 44:252-256.
29. Antaki N., Haffar S., Ali Deeb S., Assaad F., Abou Harb R., Zeibane N., et al. Syrian working group for the study of viral hepatitis. High prevalence of HBV genotype D in Syria and the clinical characteristics of hepatitis B e antigen-negative chronic hepatitis B. Epidemiol Infect 2010, 138:40-44.
30. El Chaar M., El Jisr T., Allain J.P. Hepatitis B DNA splicing in Lebanese blood donors and genotype A-E strains: implications for HBV DNA quantification and infectivity. J Clin Microbiol 2012, 10:12-1251.
31. Masaadeh H.A., Hayajneh W.A., Alqudah E.A. Hepatitis B virus genotypes and lamivudine resistance mutations in Jordan. World J Gastroenterol 2008, 14:7231-7234.
32. Specialist panel on chronic Hepatitis B in the Middle East A review of chronic hepatitis B epidemiology and management issues in selected countries in the Middle East. J Viral Hepat 2012, 19:9-22.
33. Yacoub R., Al Ali R., Moukeh G., Lahdo A., Mouhammad Y., Nasser M. Hepatitis B vaccination status and needle stick injuries among healthcare workers in Syria. J Glob Infect Dis 2010, 2:28-34.
34. Moukeh G., Yacoub R., Fahdi F., Rastam S., Albitar S. Epidemiology of hemodialysis patients in Aleppo city. Saudi J Kidney Dis Transplant 2009, 20:140-146.
35. Al-Saedy Ali J.H., Al-Kahichy Hayder R.A. The current status of hemodialysis in Baghdad. Saudi J Kidney Dis Transplant 2011, 22:362-367.
36. Kassak K., Mahfoud Z., Kreidieh K., Shamra S., Afifi R., Ramia S. Hepatitis B virus and hepatitis C virus infections among female sex workers and men who have sex with men in Lebanon: prevalence, risk behaviour and immune status. Sex Health 2011, 8:229-233.
37. Al Hijazat M., Ajlouni Y.M. Hepatitis B infection among patients receiving chronic hemodialysis at the royal medical services in Jordan. Saudi J Kidney Dis Transplant 2008, 19:260-267.
38. El-kader Y., El-Ottol A., Elmanama A.A., Ayesh B.M. Prevalence and risk factors of hepatitis B and C viruses among haemodialysis patients in Gaza strip, Palestine. Virol J 2010, 1(7):210.
39. Lehman E.M., Wilson M.L. Epidemiology of hepatitis viruses among hepatocellular carcinoma cases and healthy people in Egypt: a systematic review and meta-analysis. Int J Cancer 2009, 124:690-697.
40. Ismail A.M., Ziada H.N., Sheashaa H.A. Shehab El-Din AB. Decline of viral hepatitis prevalence among asymptomatic Egyptian blood donors: a glimmer of hope. Eur J Intern Med 2009, 20:490-493.
41. Wasfi O.A., Sadek N.A. Prevalence of hepatitis B surface antigen and hepatitis C virus antibodies among blood donors in Alexandria, Egypt. East Mediterr Health J 2011, 17:238-242.
42. Abou M.A., Eltahir Y.M., Ali A.S. Seroprevalence of hepatitis B virus and hepatitis C virus among blood donors in Nyala, South Dar Fur, Sudan. Virol J 2009, 6:146.
43. Ragheb M., Elkady A., Tanaka Y., Murakami S., Attia F.M., Hassan A.A., et al. Multiple intra-familial transmission patterns of hepatitis B virus genotype D in north-eastern Egypt. J Med Virol 2012, 84:587-595.
44. el-Sayed N.M., Gomatos P.J., Rodier G.R., Wierzba T.F., Darwish A., Khashaba S., et al. Seroprevalence survey of Egyptian tourism workers for hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and Treponema pallidum infections: association of hepatitis C virus infections with specific regions of Egypt. Am J Trop Med Hyg 1996, 55:179-184.
45. Mansour A.K., Aly R.M., Abdelrazek S.Y., Elghannam D.M., Abdelaziz S.M., Shahine D.A., et al. prevalence of HBV and HCV infection among multi-transfused Egyptian thalassemic patients. Hematol Oncol Stem Cell Ther 2012, 5:54-59.
46. Abu El Makarem M.A., Abdel Hamid M., Abdel Aleem A., Ali A., Shatat M., Sayed D., et al. Prevalence of occult hepatitis B virus infection in hemodialysis patients from Egypt with or without hepatitis C virus infection. Hepat Mon 2012, 12:253-258.
47. Elsheikh R.M., Daak A.A., Elsheikh M.A., Karsany M.S., Adam I. Hepatitis B virus and hepatitis C virus in pregnant Sudanese women. Virol J 2007, 4:104.
48. Gasim G.I., Hamdan H.Z., Hamdan S.Z., Adam I. Epidemiology of hepatitis B and hepatitis C virus infections among hemodialysis patients in Khartoum, Sudan. J Med Virol 2012, 8:52-55.
49. Ayed Z., Houinato D., Hocine M., Ranger-Rogez S., Denis F. Prevalence of serum markers of hepatitis B and C in blood donors and pregnant women in Algeria. Bull Soc Pathol Exot 1995, 88:225-228.
50. Zohoun A., Hadef R., Zahid H., Benkirane M. Seroprevalence of HBV and HCV in blood donors at the blood transfusion center of Mohammed V military teaching hospital in Rabat Morocco. Med Trop 2011, 71:513-514.
51. Sbai A., Baha W., Ougabrai H., Allalia T., Dersi N., Lazaar F., et al. Hepatitis B prevalence and risk factors in Morocco. Pathol Biol (Paris). 2012, 60:e65-9.
52. Mansour W., Malick F.Z., Sidiya A., Ishagh E., Chekaraou M.A., Veillon P., et al. Prevalence, risk factors, and molecular epidemiology of hepatitis B and hepatitis delta virus in pregnant women and in patients in Mauritania. J Med Virol 2012, 84:1186-1198.
53. Naila Hannachi, Nadia Ben Fredj, Olfa Bahri, Vincent Thibault, Asma Ferjani1, Jawhar Gharbi, et al. Molecular analysis of HBV genotypes and subgenotypes in the Central-East region of Tunisia. Virol J 2010, 7:302.
54. Khelifa F., Thibault V. Characteristics of hepatitis B viral strains in chronic carrier patients from North-East Algeria. Pathol Biol (Paris) 2009, 57:107-113.
55. Kitab B., El Feydi A.E., Afifi R., Derdabi O., Cherradi Y., Benazzouz M., et al. Hepatitis B genotypes/subgenotypes and MHR variants among Moroccan chronic carriers. J Infect 2011, 63:66-75.
56. El-Magrahe H., Furarah A.R., El-Figih K., El-Urshfany S., Ghenghesh K.S. Maternal and neonatal seroprevalence of Hepatitis B surface antigen (HBsAg) in Tripoli, Libya. J Infect Dev Ctries 2010, 29(4):168-170.
57. Franka E., El-Zoka A.H., Hussein A.H., Elbakosh M.M., Arafa A.K., Ghenghesh K.S. Hepatitis B virus and hepatitis C virus in medical waste handlers in Tripoli, Libya. J Hosp Infect 2009, 72:258-261.
58. Boulaajaj K., Elomari Y., Elmaliki B., Madkouri B., Zaid D., Benchemsi N. Prevalence of hepatitis C, hepatitis B and HIV infection among haemodialysis patients in Ibn-Rochd university hospital, Casablanca. Nephrol Ther 2005, 1:274-284.
59. Djeriri K., Laurichesse H., Merle J.L., Charof R., Abouyoub A., Fontana L., et al. Hepatitis B in Moroccan health care workers. Occup Med (Lond) 2008, 58:419-424.
60. Khan S., Attaullah S. Share of Afghanistan populace in hepatitis B and hepatitis C infection's pool: is it worthwhile?. Virol J 2011, 8:216.
61. El-Faramawy A.A., El-Rashidy O.F., Tawfik P.H., Hussein G.H. Transfusion transmitted hepatitis: where do we stand now? A one center study in upper Egypt. Hepat Mon 2012, 12:286-291.
62. Langar H., Triki H., Gouider E., Bahri O., Djebbi A., Sadraoui A., et al. Blood-transmitted viral infections among haemophiliacs in Tunisia. Transfus Clin Biol 2005, 12:301-305.
63. Al-Hawsawi Z.M. Prevalence of hepatitisC virus antibody. Ann Saudi Med 2000, 20:488-489.
64. Laperche S. Francophone African Group for Research in Blood Transfusion. Multinational assessment of blood-borne virus testing and transfusion safety on the African continent. Transfusion. 2013, 53:816-826.
65. Bjoerkvoll B., Viet L., Ol H.S., Lan N.T., Sothy S., Hoel H., et al. Screening test accuracy among potential blood donors of HBsAg, anti-HBc and anti-HCV to detect hepatitis B and C virus infection in rural Cambodia and Vietnam. Southeast Asian J Trop Med Public Health 2010, 41:1127-1135.
66. Elamin S., Abu-Aisha H. Prevention of hepatitis B virus and hepatitis C virus transmission in hemodialysis centers: review of current international recommendations. Arab J Nephrol Transplant 2011, 4:35-47.
67. Paul Nelson, Bradley Mathers, Benjamin Cowie, Holly Hagan, Don Des Jarlais, Danielle Horyniak, et al. The epidemiology of viral hepatitis among people who inject drugs: Results of global systematic reviews. Lancet 2011, 13(378):571-583.
68. Mahfoud Z., Kassak K., Kreidieh K., Shamra S., Ramia S. Prevalence of antibodies to human immunodeficiency virus (HIV), hepatitis B and hepatitis C and risk factors in prisoners in Lebanon. J Infect Dev Ctries 2010, 29(4):144-149.
69. Allwright S., Bradley F., Long J., Barry J., Thornton L., Parry J.V. Prevalence of antibodies to hepatitis B, hepatitis C. and HIV and risk factors in Irish prisoners: results of a national cross sectional survey. BMJ 2000, 8(321):78-82.
70. Deuffic-Burban S., Delarocque-Astagneau E., Abiteboul D., Bouvet E., Yazdanpanah Y. Blood-borne viruses in health care workers: prevention and management. J Clin Virol 2011, 52:4-10.
71. Mele A., Spada E., Sagliocca L., Ragni P., Tosti M.E., Gallo G., et al. Risk of parenterally transmitted hepatitis following exposure to surgery or other invasive procedures: results from the hepatitis surveillance system in Italy. J Hepatol 2001, 35:284-289.
72. De Schryver A., Claesen B., Meheus A., van Sprundel M., François G. European survey of hepatitis B vaccination policies for healthcare workers. Eur J Public Health 2011, 21:338-343.
73. Ahmed Elmukashfi T., Ali Ibrahim O., Elkhidir I.M., Ali Bashir A., Ali Awad Elkarim M. Socio-demographic characteristics of health care workers and hepatitis B virus (HBV) infection in public teaching hospitals in khartoum state, Sudan. Glob J Health Sci 2012, 214:37-41.
74. Shidrawi R., Ali Al-Huraibi M., Ahmad Al-Haimi M., Dayton R., Murray-Lyon I.M. Seroprevalence of markers of viral hepatitis in Yemeni healthcare workers. J Med Virol 2004, 73:562-565.
75. Hauri A.M., Armstrong G.L., Hutin Y.J.F. The global burden of disease attributable to contaminated injections given in health care settings. Int J Std Aids 2004, 15:7-16.
76. Hutin Y.J., Hauri A.M., Armstrong G.L. Use of injections in healthcare settings worldwide, 2000: literature review and regional estimates. BMJ 2003, 8(327):1075.
77. Roushan M.R., Mohraz M., Velayati A.A. Possible transmission of hepatitis B virus between spouses and their children in Babol, Northern Iran. Trop Doct 2007, 37:2457.
78. Ye F., Jin Y., Kong Y., Shi J.Z., Qiu H.T., Zhang X., et al. The presence of HBV mRNA in the fertilized in vitro embryo of HBV patients confirms vertical transmission of HBV via the ovum. Epidemiol Infect 2012, 9:1-5.
79. Al-Bataineh D.Hussein Azzam The prevalence of hepatitis B carrier status before and after hepatitis B vaccination. MEJFM 2005, 3:10-11.
80. Ramia S., El-Zaatari M., Sharara A.I., Ramlawi F., Farhat B. Current prevalence of hepatitis delta virus (HDV) infection and the range of HDV genotypes in Lebanon. Epidemiol Infect 2007, 135:959-962.
81. Mudawi H.M., Smith H.M., Rahoud S.A., Fletcher I.A., Saeed O.K., Fedail S.S. Prevalence of hepatitis B virus infection in the Gezira state of central Sudan. Saudi J Gastroenterol 2007, 13:81-83.
82. .
83. André F. Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine 2000, 18:S20-S22.
84. Al-Faleh F.Z., Al-Jeffri M., Ramia S., Al-Rashed R., Arif M., Rezeig M., et al. Seroepidemiology of hepatitis B virus infection in Saudi children 8 years after a mass hepatitis B vaccination programme. J Infect 1999, 38:167-170.
85. Alfaleh F., Alshehri S., Alansari S., Aljeffri M., Almazrou Y., Shaffi A., et al. Long-term protection of hepatitis B vaccine in Saudi Arabia 18years after vaccination. J Infect 2008, 57:404-409.
86. Fawzi Z., Al Hilali A., Al Malki A., Al Matawa H., Yousef B., Ali Bin Ali A., et al. Survey of hepatitis markers among donors in the State of Qatar. Qatar Med J 2007, 16:47-50.
87. Saab B.R., Nassar N.T., Musharrafieh U., Araj G.F., Khogali M. Prevalence of hepatitis B in a presumably healthy Lebanese population. J Med Liban 2007, 55:11-14.
88. Irani H.N., Musharrafieh U., Samaha H., Almawi W.Y. Prevalence of antibodies against hepatitis B virus and hepatitis C virus among blood donors in Lebanon, 1997-2003. Am J Infect Control 2006, 34:241-243.
89. Baddoura R., Haddad C., Germanos M. Hepatitis B and C seroprevalence in the Lebanese population. East Mediterr Health J 2002, 8:150-156.
90. Arthur R.R., Hassan N.F., Abdallah M.Y., el-Sharkawy M.S., Saad M.D., Hackbart B.G., et al. Hepatitis C antibody prevalence in blood donors in different governorates in Egypt. Trans R Soc Trop Med Hyg 1997, 91:271-274.
91. Mohamed M.K. Epidemiology of HCV in Egypt 2004. Afro-Arab Liver J 2004, 3:41-52.
92. Reda A.A., Arafa M.A., Youssry A.A., Wandan E.H. Ab de Ati M, Daebees H. Epidemiologic evaluation of the immunity against hepatitis B in Alexandria, Egypt. Eur J Epidemiol 2003, 18:1007-1011.
93. El-Gilany A.H., El-Fedawy S. Blood-borne infections among student voluntary blood donors in Mansoura university, Egypt. East Mediterr Health J 2006, 12:742-748.
94. Zakaria S., Esmat G., Al-Boraey Y., El-Raziky M., Fouad R., El-Garem H., et al. A community-based study of viral hepatitis infection in Giza Governorate, Egypt: Seroprevalence, risk factors and associated morbidity. Med J Cairo Univ 2005, 73:899-912.
95. Al-Owais A., Al-Suwaidi K., Amiri N., Carter A.O., Hossain M.M., Sheek-Hussein M.M. Use of existing data for public health planning: a study of the prevalence of hepatitis B surface antigen and core antibody in Al Ain Medical District, United Arab Emirates. Bull World Health Organ 2000, 78:1324-1329.
96. Mesi A, Abudher A, El-Gadi S. The seroprevalence of HIV, HBV, and HCV, among pregnant women in Tripoli - Libya: are the Libyan babies at risk?: AIDS - XVII International AIDS Conference: 2008. [Abstract no. CDC0137"].
97. Batayneh N., Bdour S. Risk of perinatal transmission of hepatitis B virus in Jordan. Infect Dis Obstet Gynecol 2002, 10:127-132.
98. El-Raziky M.S., El-Hawary M.A., Salama K.M., El-Hennawy A.M., Helmy H.M., Fahmy M.E., et al. Patterns of hepatitis B infection in Egyptian children in the era of obligatory hepatitis B vaccination. Arab J Gastroenterol 2012, 13:1-3.
99. Centers for Disease Control and Prevention "Recommendations for identification and public health management of persons with chronic hepatitis B virus infection". MMWR - Recommend Rep 2008, 57:RR-8.
100. Centers for Disease Control and Prevention Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recommend Rep 2001, 50:RR-5.